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Introduction
The glycoprotein gp120 and gp41 of HIV are the main
targets for neutralizing antibodies (NABs). It appears that
silver nanoparticles (AgNPs) also inhibit HIV-1 targeting
same glycoproteins. In this study, we demonstrated that
silver nanoparticles are efficient in neutralizing HIV-1 at
non toxic concentrations. We also found an additive
effect between the four NABs and AgNPs when com-
bined against cell-associated HIV-1 infection in vitro.
Materials and methods
The HIV-1IIIB virus, U373-MAGI-CXCR4CEM, HTLV-
IIIB, Monoclonal antibody to HIV-1 gp41 (126-7), HIV-1
gp120 Antiserum (PB1 Sub 2), HIV-1 gp120 Antiserum
(PB1), and HIV-1 gp120 Monoclonal Antibody (F425
B4e8) were obtained from the NIH AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID.
The silver nanoparticles coated with 0.2 wt% PVP were
obtained from Nanoamor, Houston, TX. Stock solutions
and serial dilution of AGNPs were prepared in RPMI 1640
cell culture media. Cytotoxicity of AgNPs was ascertained
in U373-MAGI-CXCR4CEM cells. The cell viability was
assessed using a CellTiter-Glo® Luminescent Cell Viability
Assay and Glomax Multidirection System (Promega). The
neutralizing activity of AgNPs and NABs against HIVIIIB
cell-free and cell associated virus was evaluated in an assay
involving U373-MAGI-CXCR4CEM cells, AgNPs and
NABs. Assessment of HIV-1 infection was performed with
the Beta-Glo Assay System using Glomax Multidirection
System (Promega). The percentage of residual infectivity
after NABs, AgNPs, NABS+AgNPs, or media was calcu-
lated with respect to the positive control. The 50% inhibi-
tory concentration (IC50) was defined according to the
percentage of infectivity inhibition relative to the positive
control. The inhibition data was statistically analyzed with
the help of Wilcoxon rank-sum (Wilcoxon-Mann-Whit-
ney test) test.
Results
The four NABs used in the study inhibited HIV-1 cell free
infection at a dose response manner. They were however
largely ineffective against the cell-associated virus. AgNPs
alone however were able to inhibit both cell free and cell
associated virus infection at a dose dependent manner.
AgNPs when mixed together with NABs significantly
increased inhibition of Cell associated HIV-1.
Conclusions
The addition of AgNPs to NABs has significantly
increased the neutralizing potency of NABs in preven-
tion of cell-associated HIV-1 transmission/infection.
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